TY - JOUR
T1 - Diospyros malabarica Fruit Extract Derived Silver Nanoparticles
T2 - A Biocompatible Antibacterial Agent
AU - Polash, Shakil Ahmed
AU - Hamza, Amir
AU - Hossain, Md Monir
AU - Tushar, Mehedi Hasan
AU - Takikawa, Masato
AU - Shubhra, Razib Datta
AU - Saiara, Noshin
AU - Saha, Tanushree
AU - Takeoka, Shinji
AU - Sarker, Satya Ranjan
N1 - Funding Information:
This research project was partially supported by Jahangirnagar University Research Grant 2018, University Grants Commission (UGC)-Jahangirnagar University Joint Research Grant 2019, Government of Bangladesh. SAP acknowledges National Science and Technology (NST) Fellowship (2018–2019) awarded by the Ministry of Science and Technology, Government of Bangladesh.
Publisher Copyright:
Copyright © 2022 Polash, Hamza, Hossain, Tushar, Takikawa, Shubhra, Saiara, Saha, Takeoka and Sarker.
PY - 2022/5/23
Y1 - 2022/5/23
N2 - Biogenic silver nanoparticles demonstrate excellent antibacterial activity against a broad range of bacteria. Herein, aqueous biogenic silver nanoparticles (Aq@bAgNPs) and ethanolic biogenic silver nanoparticles (Et@bAgNPs) were synthesized using aqueous as well as ethanolic extracts of Diospyros malabarica fruit, respectively. The as-prepared biogenic silver nanoparticles (bAgNPs) were characterized using UV-Vis, FTIR as well as energy dispersive X-ray (EDS) spectroscopy, electron microscopy, dynamic light scattering spectroscopy (DLS), and zetasizer. The zeta potentials of Aq@bAgNPs and Et@bAgNPs were −9.8 ± 2.6, and −12.2 ± 1.9 mV, respectively. The antibacterial activity of bAgNPs was investigated against seven bacterial strains (i.e., pathogenic and nonpathogenic) and Et@bAgNPs exhibited the highest antibacterial propensity (i.e., 20 nm in diameter) against Bacillus subtillis through disk diffusion assay. The trypan blue dye exclusion assay also confirmed the antibacterial propensity of as-prepared bAgNPs. Furthermore, both Aq@bAgNPs and Et@bAgNPs oxidize bacterial membrane fatty acids and generate lipid peroxides which eventually form complexes with thiobarbituric acid (i.e., malondialdehyde-thiobarbituric acid adduct) to bring about bacterial death. Both the nanoparticles demonstrated good hemocompatibility against human as well as rat red blood cells (RBCs). In addition, they exhibited excellent biocompatibility in vivo in terms of rat liver (i.e., serum ALT, AST, and γ-GT) and kidneys (i.e., serum creatinine) function biomarkers.
AB - Biogenic silver nanoparticles demonstrate excellent antibacterial activity against a broad range of bacteria. Herein, aqueous biogenic silver nanoparticles (Aq@bAgNPs) and ethanolic biogenic silver nanoparticles (Et@bAgNPs) were synthesized using aqueous as well as ethanolic extracts of Diospyros malabarica fruit, respectively. The as-prepared biogenic silver nanoparticles (bAgNPs) were characterized using UV-Vis, FTIR as well as energy dispersive X-ray (EDS) spectroscopy, electron microscopy, dynamic light scattering spectroscopy (DLS), and zetasizer. The zeta potentials of Aq@bAgNPs and Et@bAgNPs were −9.8 ± 2.6, and −12.2 ± 1.9 mV, respectively. The antibacterial activity of bAgNPs was investigated against seven bacterial strains (i.e., pathogenic and nonpathogenic) and Et@bAgNPs exhibited the highest antibacterial propensity (i.e., 20 nm in diameter) against Bacillus subtillis through disk diffusion assay. The trypan blue dye exclusion assay also confirmed the antibacterial propensity of as-prepared bAgNPs. Furthermore, both Aq@bAgNPs and Et@bAgNPs oxidize bacterial membrane fatty acids and generate lipid peroxides which eventually form complexes with thiobarbituric acid (i.e., malondialdehyde-thiobarbituric acid adduct) to bring about bacterial death. Both the nanoparticles demonstrated good hemocompatibility against human as well as rat red blood cells (RBCs). In addition, they exhibited excellent biocompatibility in vivo in terms of rat liver (i.e., serum ALT, AST, and γ-GT) and kidneys (i.e., serum creatinine) function biomarkers.
KW - Diospyros malabarica
KW - antibacterial activity
KW - biocompatibility
KW - hemocompatibility
KW - lipid peroxidation
UR - http://www.scopus.com/inward/record.url?scp=85131841885&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131841885&partnerID=8YFLogxK
U2 - 10.3389/fnano.2022.888444
DO - 10.3389/fnano.2022.888444
M3 - Article
AN - SCOPUS:85131841885
SN - 2673-3013
VL - 4
JO - Frontiers in Nanotechnology
JF - Frontiers in Nanotechnology
M1 - 888444
ER -